New Alliance

ATAPEX aims to break the domestic mass production gap of ultra-precision metal sheet processing. Its product business covers Display panel, display terminal, VR/AR display, including Divide Open Mask for AMOLED, Divide Fine Metal Mask, Micro OLED Open Mask for silicon-based OLED, metal support sheet for display terminal and other high-end ultra-fine processing products, connected in series A related industry chain to help customers solve various problems such as less choice of related products, unstable quality, long delivery time etc.

Lipps is a research and development, production and sales company of power semiconductor components. It can independently design IGBT/SIC, MOSFET modules and IPM module products, and has established a cooperative relationship with Japanese power module packaging factories.

NeuroXess is an invasive brain-computer interface with high-density flexible brain electrodes aimed at brain research and disease diagnosis.

Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

InnoStar Semiconductor is a semiconductor storage technology service company.

Tavotek Biotherapeutics is a biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutic medicines for patients with severe diseases that lack effective treatments. The company is led by experienced pharmaceutical executives who have successfully developed numerous biologics currently on the market. Tavotek employs three distinct research and development platforms: TavoSelect, an innovative Phage Display Library; TavoPrecise, an engineering platform for tissue-specific biologics; and TavoMIP, a multicyclic peptide platform. This diverse array of technologies supports Tavotek's extensive pipeline of product candidates, which targets cancers, autoimmune disorders, and infectious diseases, thereby addressing significant unmet medical needs in the healthcare landscape.

Biotheus Inc. is a biotechnology company founded in 2018 and headquartered in Zhuhai, China. The company specializes in the discovery and development of antibody-based therapeutics, focusing on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Its core research and development areas include tumor immunotherapy and treatments for metabolic diseases and other domestic health issues. Founded by Andy Tsun, Joanne Sun, and Xiaolin Liu, Biotheus is dedicated to advancing innovative solutions in the biopharmaceutical sector.

Biotheus Inc. is a biotechnology company founded in 2018 and headquartered in Zhuhai, China. The company specializes in the discovery and development of antibody-based therapeutics, focusing on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Its core research and development areas include tumor immunotherapy and treatments for metabolic diseases and other domestic health issues. Founded by Andy Tsun, Joanne Sun, and Xiaolin Liu, Biotheus is dedicated to advancing innovative solutions in the biopharmaceutical sector.

Developer of an online prescription platform designed to offer patient-centered services. The company's platform analyzes digital prescriptions and connects patients with appropriate pharmacists and hospitals, enabling users to simplify the process of buying prescription drugs.

Beijing Advaccine Biotechnology Co., Ltd. engages in discovery of new vaccines, both preventive and therapeutic. The company product pipeline consists respiratory syncytial virus (RSV) vaccine, type1 diabetes( T1D) therapeutic vaccine, and hepatitis B virus (HBV) therapeutic vaccine. Its vaccines help in inducing immuno-tolerance and T-cell stimulation for certain diseases. The company is based in Beijing, China.

ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.

Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that focuses on developing advanced diagnostic solutions for blood diseases. Utilizing proprietary machine-vision technology, the company has created a platform that leverages artificial intelligence for blood analysis and infectious disease detection. Its flagship product, Parasight, is a malaria detection device that accurately identifies and enumerates malaria through a digital fluorescent microscopy process. Since its launch in 2014, Sight Diagnostics has sold over 600,000 tests across 25 countries. Additionally, the company has introduced OLO, a device that facilitates complete blood count testing at the point-of-care, which is currently available in the European Union and other non-US markets. By providing scalable and precise blood diagnostics, Sight Diagnostics aims to enhance patient outcomes and improve overall healthcare accessibility.

CapitalBio Technology Co., Ltd. is a life science company based in Beijing, China, specializing in the development and commercialization of healthcare solutions. Founded in 2012, it offers a wide range of products including nucleic acid detection kits for respiratory pathogens and Hepatitis B virus, as well as a Thalassemia gene mutations detection kit. The company also provides microarray and microfluidic chips, along with related instruments, software, reagents, and consumables for various applications such as clinical diagnostics, drug development, and molecular breeding. Additionally, CapitalBio Technology offers services including SNP analysis, mRNA expression profiling, DNA methylation detection, and sequencing. As a subsidiary of CapitalBio Corporation, the company is equipped with over 35,000 square meters of office space and employs more than 500 staff members, the majority of whom hold advanced degrees.

Biotheus Inc. is a biotechnology company founded in 2018 and headquartered in Zhuhai, China. The company specializes in the discovery and development of antibody-based therapeutics, focusing on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Its core research and development areas include tumor immunotherapy and treatments for metabolic diseases and other domestic health issues. Founded by Andy Tsun, Joanne Sun, and Xiaolin Liu, Biotheus is dedicated to advancing innovative solutions in the biopharmaceutical sector.

QST Corporation, founded in September 2012 and based in Shanghai, China, specializes in the design, research, and development of MEMS sensors and smart applications tailored for mobile consumer electronics and IoT applications. The company offers a range of high-quality sensor products, including 3-axis magnetic sensors, accelerometers, gyroscopes, barometers, pressure sensors, light sensors, and combined inertial sensors. QST Corporation focuses on customizing intelligent applications and services to meet the specific needs of its clients. The company has experienced rapid growth by leveraging the virtual IDM model and utilizing China's domestic industrial support system.

Beijing Advaccine Biotechnology Co., Ltd. engages in discovery of new vaccines, both preventive and therapeutic. The company product pipeline consists respiratory syncytial virus (RSV) vaccine, type1 diabetes( T1D) therapeutic vaccine, and hepatitis B virus (HBV) therapeutic vaccine. Its vaccines help in inducing immuno-tolerance and T-cell stimulation for certain diseases. The company is based in Beijing, China.

CF PharmTech, Inc. develops and manufactures inhalation products. The company’s products include metered dose inhaler (MDI), dry powder inhalers (DPI), nasal sprays, nebulizer, and respiratory medicines. It provides contract manufacturing organization (CMO) services. It conducts research and development in the areas of asthma, chronic obstructive pulmonary disease (COPD), and rhinitis. The company was founded in 2007 and is based in Suzhou, China.

Innoviz is a manufacturer of solid-state LiDAR sensors and perception software that enable the mass-production of autonomous vehicles. InnovizPro is a solid-state LiDAR that offers outstanding performance and value for automotive and other applications. InnovizOne is a cutting-edge, automotive-grade LiDAR sensor that provides superior 3D sensing for Level 3-Level 5 autonomous driving. The company is backed by top-tier strategic partners and investors, including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital (SINO-BLR Industrial Investment Fund, L.P.), 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company, and others.

Innoviz is a manufacturer of solid-state LiDAR sensors and perception software that enable the mass-production of autonomous vehicles. InnovizPro is a solid-state LiDAR that offers outstanding performance and value for automotive and other applications. InnovizOne is a cutting-edge, automotive-grade LiDAR sensor that provides superior 3D sensing for Level 3-Level 5 autonomous driving. The company is backed by top-tier strategic partners and investors, including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital (SINO-BLR Industrial Investment Fund, L.P.), 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company, and others.

Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that focuses on developing advanced diagnostic solutions for blood diseases. Utilizing proprietary machine-vision technology, the company has created a platform that leverages artificial intelligence for blood analysis and infectious disease detection. Its flagship product, Parasight, is a malaria detection device that accurately identifies and enumerates malaria through a digital fluorescent microscopy process. Since its launch in 2014, Sight Diagnostics has sold over 600,000 tests across 25 countries. Additionally, the company has introduced OLO, a device that facilitates complete blood count testing at the point-of-care, which is currently available in the European Union and other non-US markets. By providing scalable and precise blood diagnostics, Sight Diagnostics aims to enhance patient outcomes and improve overall healthcare accessibility.

Thousand Oaks Biopharmaceuticals, Inc. is a biotechnology company based in Haimen, China, specializing in contract development and manufacturing services for the biopharmaceutical industry. Established in 2017, the company focuses on developing biopharmaceutical technologies that enhance the production of protein and vaccine compounds. It offers integrated control solutions designed to optimize production processes, improve protein expression, and reduce production scale. Additionally, Thousand Oaks provides personalized, chemically-defined cell culture media, formula production, technical support, and ancillary services to its clients. The company also operates a healthcare receivable management platform that enhances patient collections, reduces operational costs, and increases revenue for healthcare providers through effective revenue cycle management and technology-driven solutions.

ZStack Cloud Platform has served more than 1,000 enterprise users and established ecological and channel partnerships with more than 200 cloud vendors, covering government, finance, education, internet, energy, manufacturing and many other industries.

ShopEx is an e-commerce software and service provider in China. It focuses on the research and development of e-commerce software and provision of related solutions and services. ShopEx has become the largest and most experienced professional team and develops e-commerce software with independent core technology and intellectual property rights and services.

Banma Kuaipao develops a mobile application for freight transportation. It also operates mobile applications to book cabs and buses for travelling. Li Jia founded Banman Kuaipao in July 2015. Its headquarters is in Wuhan in China.

Shenzhen Jiedian Technology is a mobile device power bank rental start-up.

CooTek (NYSE: CTK), founded in 2008, listed on NYSE on September 28th, 2018, is a global and fast-growing mobile internet company that develops innovative mobile apps and artificial intelligence technology. With a massive global user base, CooTek aims to empower users to express themselves and enjoy relevant content seamlessly. CooTek’s flagship mobile app, TouchPal Keyboard, uses unparalleled technology to provide the best input experience to both Android and iPhone users. CooTek has also developed many content-rich apps, spanning across 5 selected verticals including fitness, lifestyle, healthcare, news and short videos, and entertainment. In September 2018, CooTek’s global products reached an average of 213.7 million monthly active users around the world. Headquartered in Shanghai, CooTek offices can be found in Silicon Valley, Beijing, Taipei, Guangzhou, and Shenzhen. Today, CooTek has over 170 patent applications and granted patents worldwide and continually pursue excellence in technology innovation and intellectual property development. CooTek has also established its own big data development center and AI lab in Silicon Valley. Many academic papers written by CooTek have been used in discussions at world-renowned big data and AI conferences such as AAAI, KDD and CIKM.

Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that focuses on developing advanced diagnostic solutions for blood diseases. Utilizing proprietary machine-vision technology, the company has created a platform that leverages artificial intelligence for blood analysis and infectious disease detection. Its flagship product, Parasight, is a malaria detection device that accurately identifies and enumerates malaria through a digital fluorescent microscopy process. Since its launch in 2014, Sight Diagnostics has sold over 600,000 tests across 25 countries. Additionally, the company has introduced OLO, a device that facilitates complete blood count testing at the point-of-care, which is currently available in the European Union and other non-US markets. By providing scalable and precise blood diagnostics, Sight Diagnostics aims to enhance patient outcomes and improve overall healthcare accessibility.

Provider of film and television content focusing on project planning, content production, and media operations. The company has strategic cooperation with BBC, Disney and Fuji TV and has strong domestic and overseas distribution capabilities, providing customers with high-quality media content globally.